Most Recent
Apotex settles patent suit over generic Lexapro
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
AFT Pharma’s Maxigesic ads misleading, judge rules
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
Wyeth resolves Commonwealth’s claims over generic Effexor delay
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Guthrie files action against ABC over her sacking
Former ABC boss Michelle Guthrie has launched legal proceedings over her firing last month from the ABC, making an adverse action claim against the broadcaster.
Arrium creditors can get docs for potential litigation over $4B collapse
Creditors of the failed Arrium Group have won access to documents handed over by third parties to the company's administrators for possible civil proceedings against the steel producer, which collapsed owing $2.3 billion.
Optus agrees to pay $10M for misleading customers over phone bills
Optus has agreed to fork over $10 million in penalties after admitting it billed customers for premium phone services they didn't sign up for, the consumer watchdog said Wednesday.
Clock’s ticking as Unlockd gets deadline for filing case against Google
Failed digital ad company Unlockd has until the end of the month to set out its competition case against Google or the suit will be thrown out.
Westpac appeals funding order in life insurance class action
Westpac is challenging a judge's order that gives the funder backing a class action over life insurance premiums a 25 percent cut of any recovery.
ASIC bans fourth NAB banker over home loan fraud scam
Former National Australia Bank branch manager Mathew Alwan has been permanently banned from the financial services industry for his involvement in a home loan fraud ring in greater western Sydney.
Aviation 3030 investor can’t duck security because of ASIC’s suit
An investor suing property investment group Aviation 3030 can't avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.